FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2784073016> ?p ?o ?g. }

• W2784073016 endingPage "297" @default.
• W2784073016 startingPage "286" @default.
• W2784073016 abstract "Background: Most patients with chronic heart failure have detectable troponin concentrations when evaluated by high-sensitivity assays. The prognostic relevance of this finding has not been clearly established so far. We aimed to assess high-sensitivity troponin assay for risk stratification in chronic heart failure through a meta-analysis approach. Methods: Medline, EMBASE, Cochrane Library, and Scopus were searched in April 2017 by 2 independent authors. The terms were “troponin” AND “heart failure” OR “cardiac failure” OR “cardiac dysfunction” OR “cardiac insufficiency” OR “left ventricular dysfunction.” Inclusion criteria were English language, clinical stability, use of a high-sensitivity troponin assay, follow-up studies, and availability of individual patient data after request to authors. Data retrieved from articles and provided by authors were used in agreement with the PRISMA statement. The end points were all-cause death, cardiovascular death, and hospitalization for cardiovascular cause. Results: Ten studies were included, reporting data on 11 cohorts and 9289 patients (age 66±12 years, 77% men, 60% ischemic heart failure, 85% with left ventricular ejection fraction <40%). High-sensitivity troponin T data were available for all patients, whereas only 209 patients also had high-sensitivity troponin I assayed. When added to a prognostic model including established risk markers (sex, age, ischemic versus nonischemic etiology, left ventricular ejection fraction, estimated glomerular filtration rate, and N-terminal fraction of pro-B-type natriuretic peptide), high-sensitivity troponin T remained independently associated with all-cause mortality (hazard ratio, 1.48; 95% confidence interval, 1.41–1.55), cardiovascular mortality (hazard ratio, 1.40; 95% confidence interval, 1.33–1.48), and cardiovascular hospitalization (hazard ratio, 1.42; 95% confidence interval, 1.36–1.49), over a median 2.4-year follow-up (all P <0.001). High-sensitivity troponin T significantly improved risk prediction when added to a prognostic model including the variables above. It also displayed an independent prognostic value for all outcomes in almost all population subgroups. The area under the curve–derived 18 ng/L cutoff yielded independent prognostic value for the 3 end points in both men and women, patients with either ischemic or nonischemic etiology, and across categories of renal dysfunction. Conclusions: In chronic heart failure, high-sensitivity troponin T is a strong and independent predictor of all-cause and cardiovascular mortality, and of hospitalization for cardiovascular causes, as well. This biomarker then represents an additional tool for prognostic stratification." @default.
• W2784073016 created "2018-01-26" @default.
• W2784073016 creator A5004466344 @default.
• W2784073016 creator A5005350140 @default.
• W2784073016 creator A5016571179 @default.
• W2784073016 creator A5018464718 @default.
• W2784073016 creator A5021118761 @default.
• W2784073016 creator A5022627688 @default.
• W2784073016 creator A5024386124 @default.
• W2784073016 creator A5027518592 @default.
• W2784073016 creator A5029606867 @default.
• W2784073016 creator A5031658795 @default.
• W2784073016 creator A5035023430 @default.
• W2784073016 creator A5035769119 @default.
• W2784073016 creator A5037049795 @default.
• W2784073016 creator A5037939005 @default.
• W2784073016 creator A5039625009 @default.
• W2784073016 creator A5042358240 @default.
• W2784073016 creator A5043064522 @default.
• W2784073016 creator A5048432854 @default.
• W2784073016 creator A5050177584 @default.
• W2784073016 creator A5056510829 @default.
• W2784073016 creator A5057864298 @default.
• W2784073016 creator A5071905871 @default.
• W2784073016 creator A5077862111 @default.
• W2784073016 creator A5082700741 @default.
• W2784073016 creator A5085294412 @default.
• W2784073016 creator A5086823665 @default.
• W2784073016 creator A5086850743 @default.
• W2784073016 creator A5087136011 @default.
• W2784073016 creator A5088399069 @default.
• W2784073016 creator A5091506728 @default.
• W2784073016 date "2018-01-16" @default.
• W2784073016 modified "2023-10-16" @default.
• W2784073016 title "Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure" @default.
• W2784073016 cites W1483312747 @default.
• W2784073016 cites W1900173585 @default.
• W2784073016 cites W1966329493 @default.
• W2784073016 cites W1989231226 @default.
• W2784073016 cites W1996444735 @default.
• W2784073016 cites W1997414007 @default.
• W2784073016 cites W2007347162 @default.
• W2784073016 cites W2025645069 @default.
• W2784073016 cites W2030151847 @default.
• W2784073016 cites W2033723052 @default.
• W2784073016 cites W2056893352 @default.
• W2784073016 cites W2067381697 @default.
• W2784073016 cites W2074847887 @default.
• W2784073016 cites W2075477337 @default.
• W2784073016 cites W2079911401 @default.
• W2784073016 cites W2084656663 @default.
• W2784073016 cites W2087399366 @default.
• W2784073016 cites W2091203293 @default.
• W2784073016 cites W2092444466 @default.
• W2784073016 cites W2095056452 @default.
• W2784073016 cites W2098105324 @default.
• W2784073016 cites W2108173419 @default.
• W2784073016 cites W2118064158 @default.
• W2784073016 cites W2119605658 @default.
• W2784073016 cites W2125435699 @default.
• W2784073016 cites W2126452437 @default.
• W2784073016 cites W2136816069 @default.
• W2784073016 cites W2137670391 @default.
• W2784073016 cites W2139661174 @default.
• W2784073016 cites W2151231511 @default.
• W2784073016 cites W2153776328 @default.
• W2784073016 cites W2156683561 @default.
• W2784073016 cites W2159383682 @default.
• W2784073016 cites W2167075471 @default.
• W2784073016 cites W2427094903 @default.
• W2784073016 cites W2526425095 @default.
• W2784073016 cites W2531618711 @default.
• W2784073016 cites W2546606462 @default.
• W2784073016 cites W2548455412 @default.
• W2784073016 cites W2647973374 @default.
• W2784073016 cites W4211082352 @default.
• W2784073016 cites W4293872547 @default.
• W2784073016 cites W4294215472 @default.
• W2784073016 doi "https://doi.org/10.1161/circulationaha.117.031560" @default.
• W2784073016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29335288" @default.
• W2784073016 hasPublicationYear "2018" @default.
• W2784073016 type Work @default.
• W2784073016 sameAs 2784073016 @default.
• W2784073016 citedByCount "142" @default.
• W2784073016 countsByYear W27840730162018 @default.
• W2784073016 countsByYear W27840730162019 @default.
• W2784073016 countsByYear W27840730162020 @default.
• W2784073016 countsByYear W27840730162021 @default.
• W2784073016 countsByYear W27840730162022 @default.
• W2784073016 countsByYear W27840730162023 @default.
• W2784073016 crossrefType "journal-article" @default.
• W2784073016 hasAuthorship W2784073016A5004466344 @default.
• W2784073016 hasAuthorship W2784073016A5005350140 @default.
• W2784073016 hasAuthorship W2784073016A5016571179 @default.
• W2784073016 hasAuthorship W2784073016A5018464718 @default.
• W2784073016 hasAuthorship W2784073016A5021118761 @default.
• W2784073016 hasAuthorship W2784073016A5022627688 @default.
• W2784073016 hasAuthorship W2784073016A5024386124 @default.

• next